Article
Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon.
Journal of the American Medical Directors Association
Document Type
Citation
Publication Date
1-28-2021
Disciplines
Abstract
Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.
Rights
© 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Locate the Document
DOI
10.1016/j.jamda.2020.12.030
Persistent Identifier
https://archives.pdx.edu/ds/psu/35335
Citation Information
Dys, S., Tunalilar, O., & Carder, P. (2021). Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon. Journal of the American Medical Directors Association, S1525861020310975. https://doi.org/10.1016/j.jamda.2020.12.030